SAVE THE DATE!
January 8–10, 2024San Francisco, CAkeyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 2 - January 10 - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 2 - January 10 - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
All times are in PST
08:00 - 09:0060 mins
Biotech Showcase 1
Gene & Cell Therapy: Innovative Approaches Making an Impact
- Ramin Baghirzade - Senior Director, Global Head Commercial, Gene Therapy CDMO Services, Charles River
- Daniel Dornbusch - CEO, Excision BioTherapeutics
- William Ho - Founder, President and CEO, IN8bio
- Daniel Oliver - CEO, Rejuvenate Bio
- Lex Rovner - CEO, 64x Bio
- Richard Wilson - Senior VP, Primary Focus Lead Genetic Regulation, Astellas Pharma
08:00 - 09:0060 mins
Digital Medicine and Medtech Showcase
Bioelectronic Medicine: Electrifying Investor Interest
- James Cavuoto - Editor & Publisher, Neurotech Reports
- Carolina Aguilar - CEO, INBRAIN Neuroelectronics
- Imran Eba - Partner, Action Potential Venture Capital
- Victor Pikov - CEO, Medipace
08:00 - 18:00600 mins
One-to-one meetings
Partnering: One-to-one meetings
09:00 - 10:0060 mins
Asia Pacific Showcase
BioPharma Business in the Asia Pacific Region: Huge Markets, Great Opportunities
- Martina Molsbergen - CEO, C14 Consulting Group LLC
- Kevin Huh - CEO, Korea Innovative Medicines Consortium
- Darren Ji - Co-Founder, CEO, Elpiscience
- Shigeru Kobayashi - Chairman, President & CEO, Chiome Bioscience Inc.
- Deborah Rathjen - CEO, Carina Biotech
10:00 - 11:0060 mins
Digital Medicine and Medtech Showcase
Business Panel: State of The Digital Healthcare Industry
- Amy Leiser - Associate, Covington
- Derk Arts - Founder & CEO, Castor
- Anne Bailey - Director, Clinical Tech Innovation, U.S. Department of Veterans Affairs
- Beth Rogozinski - CEO, Oncoustics
12:00 - 13:3090 mins
Biotech Showcase 1
The Inflation Reduction Act (IRA): The Dawn of a New Era - What Will it Mean for Innovation?
- Simone Fishburn - VP and Editor-in-Chief, BioCentury
- Alex Harding - Head of Business Development, CRISPR Therapeutics
- Paul Hastings - President and CEO, Nkarta Therapeutics
- Jeff Myers - President and CEO, Medicaid Health Plans of America
- Peter Rubin - Executive Director, No Patient Left Behind
- Alice Valder Curran - Partner, Hogan Lovells
14:00 - 14:3030 mins
Digital Medicine and Medtech Showcase
Biogen Fireside Chat: Digital therapeutics (Dtx): Building the next stage of Pharma-DTx partnerships to positively impact patient outcomes
- Uma Verma - Senior Director, Business Development, Biogen
- Stephen Bruso - Investor, Morning Side Ventures
- Michael Ludwig - Partner, MTS Health Partners
- Owen McCarthy - President, MedRhythms
- James Williams - Head of Biogen Digital Health Ventures, Biogen
14:30 - 15:3060 mins
Asia Pacific Showcase
BioPharma Investment Trends in the Asia Pacific Region: What you Need to Know
- Vivian Lee - Managing Director, Aqua Partners LLC
- Ryutaro Adachi - Director, Corporate Venture Investment, Eisai Co. Ltd.
- Jeremy Curnock Cook - Managing Partner, Bioscience Managers
- Elizabeth Kelly - Principal, Pappas Capital
- Yuwen Liu - Founding Partner, Bohe Angel Fund
15:30 - 16:0030 mins
Biotech Showcase 1
Capital Preservation: How to Preserve Capital and Retain Control of Your Research
- Steve Brozak - President, WBB Securities LLC
- Ann Murray - Global Senior Director, Business Development, Charles River Labs
16:00 - 17:0060 mins
Biotech Showcase 1
Dealmakers’ Intentions 2023
- Neel Patel - Executive Managing Director, Head Commercial Advisory Group - Consulting, Syneos Health Consulting
- Dawn Bell - Global Development Head, Strategic Partnerships Team, BIOME by Novartis
- Akshay Chellappa - Director, Corporate Development, Gilead
- Ali Pashazadeh - Founder, Treehill Partners
- Jaisim Shah - CEO & President, Scilex
Filter
Streams
Formats